8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 12, 2024 · 2y ago · Accession 0001628280-24-027816
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Prime Medicine, Inc.
- Ticker
- PRME
- CIK
- 1894562
- Form type
- 8-K
- Filing date
- Jun 12, 2024
- Report date
- Jun 12, 2024
- Document
- prme-20240612.htm
- Size
- 225 KB